Lung Adenocarcinoma Latest Advances

miR-1910-3p affects proliferation, invasion and in vivo tumor growth of lung adenocarcinoma by inducing epithelial-mesenchymal transition

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: June 22, 2026

Transcription factor TFAP2A upregulates CDC6 to mediate glycolysis and promote stemness in lung adenocarcinoma cells.

Journal: Histology and histopathology

Published: June 22, 2026

SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Corrigendum to "STRIP2 confers acquired resistance to EGFR-TKIs in lung adenocarcinoma by modulating IGF2BP3-dependent Twist1 stability" [Genomics 118 (2026) 4:111262].

Journal: Genomics

Published: June 20, 2026

RETRACTION: FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.

Journal: Thoracic cancer

Published: June 17, 2026

Personalized Pathogenic Nanoplastic Coronas Orchestrate Efferocytosis-Driven Immune Evasion in Lung Adenocarcinoma.

Journal: ACS nano

Published: June 17, 2026

Attenuation- and Entropy-Based Habitat Imaging for High-Risk Features in Lung Adenocarcinoma Presenting as a Part-Solid Nodule on CT: A Multicenter Study.

Journal: AJR. American journal of roentgenology

Published: June 17, 2026

Correction to "FHL2 Expression by Cancer-Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma".

Journal: International journal of cancer

Published: June 15, 2026

Robotic right upper sleeve lobectomy with bronchoplasty for primary adenocarcinoma.

Journal: Multimedia manual of cardiothoracic surgery : MMCTS

Published: June 15, 2026

Glycolytic Reprogramming in Lung Adenocarcinoma: Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 15, 2026

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 15, 2026

Discovery of a Covalent Inhibitor Targeting the PHGDH Dimer Interface with Antitumor Efficacy.

Journal: Journal of medicinal chemistry

Published: June 12, 2026

Lung Adenocarcinoma Latest Advances

Find the Latest Research About Lung Adenocarcinoma

miR-1910-3p affects proliferation, invasion and in vivo tumor growth of lung adenocarcinoma by inducing epithelial-mesenchymal transition

miR-1910-3p affects proliferation, invasion and in vivo tumor growth of lung adenocarcinoma by inducing epithelial-mesenchymal transition

Transcription factor TFAP2A upregulates CDC6 to mediate glycolysis and promote stemness in lung adenocarcinoma cells.

Transcription factor TFAP2A upregulates CDC6 to mediate glycolysis and promote stemness in lung adenocarcinoma cells.

SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

Corrigendum to "STRIP2 confers acquired resistance to EGFR-TKIs in lung adenocarcinoma by modulating IGF2BP3-dependent Twist1 stability" [Genomics 118 (2026) 4:111262].

Corrigendum to "STRIP2 confers acquired resistance to EGFR-TKIs in lung adenocarcinoma by modulating IGF2BP3-dependent Twist1 stability" [Genomics 118 (2026) 4:111262].

RETRACTION: FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.

RETRACTION: FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.

Personalized Pathogenic Nanoplastic Coronas Orchestrate Efferocytosis-Driven Immune Evasion in Lung Adenocarcinoma.

Personalized Pathogenic Nanoplastic Coronas Orchestrate Efferocytosis-Driven Immune Evasion in Lung Adenocarcinoma.

Attenuation- and Entropy-Based Habitat Imaging for High-Risk Features in Lung Adenocarcinoma Presenting as a Part-Solid Nodule on CT: A Multicenter Study.

Attenuation- and Entropy-Based Habitat Imaging for High-Risk Features in Lung Adenocarcinoma Presenting as a Part-Solid Nodule on CT: A Multicenter Study.

Correction to "FHL2 Expression by Cancer-Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma".

Correction to "FHL2 Expression by Cancer-Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma".

Robotic right upper sleeve lobectomy with bronchoplasty for primary adenocarcinoma.

Robotic right upper sleeve lobectomy with bronchoplasty for primary adenocarcinoma.

Glycolytic Reprogramming in Lung Adenocarcinoma: Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies

Glycolytic Reprogramming in Lung Adenocarcinoma: Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment

Discovery of a Covalent Inhibitor Targeting the PHGDH Dimer Interface with Antitumor Efficacy.

Discovery of a Covalent Inhibitor Targeting the PHGDH Dimer Interface with Antitumor Efficacy.

Glycolytic Reprogramming in Lung Adenocarcinoma: Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies

Glycolytic Reprogramming in Lung Adenocarcinoma: Molecular Mechanisms, Metabolic Biomarkers and Targeted Therapeutic Strategies